scholarly journals An Alternative to Antibiotics: Selected Methods to Combat Zoonotic Foodborne Bacterial Infections

2021 ◽  
Author(s):  
Ewelina Łojewska ◽  
Tomasz Sakowicz
Keyword(s):  
Foodborne Pathogens ◽  
Bacterial Infections ◽  
Pathogenic Bacteria ◽  
Bacterial Resistance ◽  
Animal Feed ◽  
Health Sector ◽  
Resistance Mechanisms ◽  
Economic Losses ◽  
Nonculturable Cells ◽  
Induce Resistance

AbstractPathogenic bacteria contaminating food or animal feed cause serious economic losses in the health sector as well as is in the agriculture and food industry. The development of bacterial resistance due to the misuse of antibiotics and chemicals, especially in the farm industry, can bring dangerous effects for the global population therefore new safe biological antimicrobial solutions are urgently needed. In this paper, we investigate biological alternatives to antibiotics against foodborne pathogens. The most promising alternatives include antimicrobial proteins, bacteriophages, probiotics, and plant-based substances. Each described group of substances is efficient against specific foodborne bacteria and has a preferred use in an explicit application. The advantages and drawbacks of each method are outlined in the final section. Biological antibacterial solutions are usually easily degradable. In contrast to antibiotics or chemical/physical methods, they are also far more specific. When introducing new antibacterial methods it is crucial to check their safety and ability to induce resistance mechanisms. Moreover, it is important to assess its activity to inhibit or kill in viable but nonculturable cells (VBNC) state and biofilm forms. VBNC bacteria are considered a threat to public health and food safety due to their possibility of remaining viable and virulent. Biological alternatives to antibiotics complete the majority of the advantages needed for a safe and efficient antimicrobial product. However, further research is necessary to fully implement those solutions to the market.

scholarly journals The Use of Bacteriophages in the Poultry Industry

Animals ◽  
2020 ◽  
Vol 10 (5) ◽  
pp. 872 ◽  
Author(s):  
Katarzyna Żbikowska ◽  
Monika Michalczuk ◽  
Beata Dolka
Keyword(s):  
Foodborne Pathogens ◽  
Pathogenic Bacteria ◽  
Bacterial Resistance ◽  
Health And Safety ◽  
Legal Framework ◽  
Multidrug Resistant ◽  
Poultry Production ◽  
Salmonella Spp ◽  
Food Contact Surfaces ◽  
Public Health And Safety

The emergence of multidrug-resistant infections and antibiotic failures have raised concerns over human and veterinary medicine worldwide. Poultry production has had to confront the problems of an alarming increase in bacterial resistance, including zoonotic pathogens. According to the European Food Safety Authority (EFSA), campylobacteriosis and salmonellosis have been the most frequently reported human foodborne diseases linked to poultry. This situation has strongly stimulated a renewal of scientists’ interest in bacteriophages (phages) since the beginning of the 21st century. Bacteriophages are the viruses of bacteria. They are abundant in nature, and accompany bacteria in each environment they colonize, including human microbiota. In this review, we focused on the use of bacteriophages as therapeutic agents to treat infections and reduce counts of pathogenic bacteria in poultry, as biocontrol agents to eliminate foodborne pathogens on/in food, and also as disinfectants to reduce contamination on food-contact surfaces or poultry carcasses in industrial conditions. Most of the phage-based products are targeted against the main foodborne pathogens, such as Campylobacter jejuni, Salmonella spp., Escherichia coli, Listeria monocytogenes, Staphylococcus aureus, and Clostridium perfringens. Phages are currently addressed at all stages of the poultry production "from farm to fork", however, their implementation into live birds and food products still provokes discussions especially in the context of the current legal framework, limitations, as well as public health and safety.

scholarly journals Phages as a Cohesive Prophylactic and Therapeutic Approach in Aquaculture Systems

Antibiotics ◽  
2020 ◽  
Vol 9 (9) ◽  
pp. 564 ◽  
Author(s):  
Maciej Żaczek ◽  
Beata Weber-Dąbrowska ◽  
Andrzej Górski
Keyword(s):  
Antibiotic Resistance ◽  
Bacterial Infections ◽  
Pathogenic Bacteria ◽  
Human Life ◽  
Natural Habitat ◽  
Aquatic Organisms ◽  
Economic Losses ◽  
Complex Approach ◽  
Promising Solution ◽  
Phage Treatment

Facing antibiotic resistance has provoked a continuously growing focus on phage therapy. Although the greatest emphasis has always been placed on phage treatment in humans, behind phage application lies a complex approach that can be usefully adopted by the food industry, from hatcheries and croplands to ready-to-eat products. Such diverse businesses require an efficient method for combating highly pathogenic bacteria since antibiotic resistance concerns every aspect of human life. Despite the vast abundance of phages on Earth, the aquatic environment has been considered their most natural habitat. Water favors multidirectional Brownian motion and increases the possibility of contact between phage particles and their bacterial hosts. As the global production of aquatic organisms has rapidly grown over the past decades, phage treatment of bacterial infections seems to be an obvious and promising solution in this market sector. Pathogenic bacteria, such as Aeromonas and Vibrio, have already proved to be responsible for mass mortalities in aquatic systems, resulting in economic losses. The main objective of this work is to summarize, from a scientific and industry perspective, the recent data regarding phage application in the form of targeted probiotics and therapeutic agents in aquaculture niches.

Versatile polymer-based strategies for antibacterial drug delivery systems and antibacterial coatings

2022 ◽  
Author(s):  
Kexin You ◽  
Bin Gao ◽  
Meiyu Wang ◽  
Xiaoyu Wang ◽  
Kingsley Chidiebere Okoro ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Human Health ◽  
Bacterial Infections ◽  
Drug Delivery Systems ◽  
Bacterial Resistance ◽  
Economic Losses ◽  
Antibacterial Drug ◽  
Antibacterial Materials ◽  
Human Health Damage ◽  
Health Damage

Human health damage and economic losses due to bacterial infections are very serious worldwide. Excessive use of antibiotics has caused an increase in bacterial resistance. Fortunately, various non-antibiotic antibacterial materials...

Combating bacterial resistance by combination of antibiotics with antimicrobial peptides

2019 ◽  
Vol 91 (2) ◽  
pp. 199-209 ◽  
Author(s):  
Dean E. Sheard ◽  
Neil M. O’Brien-Simpson ◽  
John D. Wade ◽  
Frances Separovic
Keyword(s):  
Antimicrobial Peptides ◽  
Bacterial Infections ◽  
Bacterial Resistance ◽  
Synergistic Effects ◽  
Resistance Mechanisms ◽  
Bacterial Strains ◽  
Diverse Range ◽  
Recent Emergence ◽  
Agricultural Industries ◽  
Conventional Antibiotics

Abstract The overuse of antibiotics in the healthcare and agricultural industries has led to the worldwide spread of bacterial resistance. The recent emergence of multidrug resistant (MDR) bacteria has resulted in a call for the development of novel strategies to address this global issue. Research on a diverse range of antimicrobial peptides (AMPs) has shown promising activity against several resistant strains. Increased understanding of the mode of action of AMPs has shown similarity and complementarity to conventional antibiotics and the combination of both has led to synergistic effects in some cases. Combination therapy has been widely used to combat MDR bacterial infections and the recent focus on their application with AMPs may allow antibiotics to be effective against resistant bacterial strains. By conjugation of an antibiotic onto an AMP, a compound may be produced with possibly greater activity and with reduced side-effects and toxicity. The AMP in these conjugates may also act as a unique adjuvant for the antibiotic by disrupting the resistance mechanisms used by bacteria thus allowing the antibiotic to once again be effective. This mini-review outlines some of the current and past work in combining AMPs with conventional antibiotics as strategies to address bacterial resistance.

scholarly journals Mechanism of BceAB-type transporter: Resistance by lipid II flipping

2020 ◽  
Author(s):  
Julia Zaschke-Kriesche ◽  
Sandra Unsleber ◽  
Irina Voitsekhovskaia ◽  
Andreas Kulik ◽  
Lara V. Behrmann ◽  
...  
Keyword(s):  
Cell Wall ◽  
Antimicrobial Peptides ◽  
Streptococcus Agalactiae ◽  
Bacterial Infections ◽  
Pathogenic Bacteria ◽  
Resistance Mechanism ◽  
Resistance Mechanisms ◽  
Human Pathogenic Bacteria ◽  
Lipid Ii ◽  
Multiresistant Bacteria

AbstractTreatment of bacterial infections are the great challenge of our era due to the evolved resistance mechanisms against antibiotics. The Achilles heel of bacteria is the cell wall especially during the needs of its synthesis and cell division. Here lipid II is an essential cell wall precursor component synthesized in the cytosol and flipped into the outer leaflet of the membrane prior to its incorporation into the cell wall.Compounds targeting the cell wall or its biosynthesis precursors have been around for decades and have been used as antibiotics against bacterial infections like meningitis, pneumonia and endocarditis. Antimicrobial peptides (AMPs) have proven to be a promising weapon against multiresistant bacteria. However, the Bacitracin efflux (BceAB)-type ATP binding cassette transporters expressed in the membrane of human pathogenic bacteria have been shown to confer resistance to these alternative antibiotics, thereby hampering their medical development.In Streptococcus agalactiae COH1 the BceAB-type transporter NsrFP (SaNsrFP) confers high-level resistance against the antimicrobial peptide nisin, a member of the lantibiotic subfamily. We showed that SaNsrFP provides a novel resistance mechanism by flipping lipid II back into the cytosol, thereby preventing the binding of nisin as well as other lipid II targeting compounds. This is intriguing since a relatively simple reaction mediates resistance to human pathogenic bacteria to lipid II targeting antibiotics, regardless of their structure.Significance StatementThe ABC-transporter NsrFP from Streptococcus agalactiae (SaNsrFP) belongs to the BceAB-type transporters. Several BceAB-type transporters are known to confer resistance against multiple antimicrobial peptides. In this study a new resistance mechanism was identified, which is based on the reduction of the number of cell wall precursor lipid II molecules on the cell surface mediated by SaNsrFP. SaNsrFP flips lipid II, which are considered to be the target for many antibiotics, back into the cytoplasm. With this newly gained knowledge about the resistance mechanism of BceAB-type transporters, novel strategies can be established to overcome or bypass this resistance in human pathogenic bacteria.

scholarly journals Multidrug-Resistant Bacterial Foodborne Pathogens: Impact on Human Health and Economy

2020 ◽  
Author(s):  
Lilia M. Mancilla-Becerra ◽  
Teresa Lías-Macías ◽  
Cristina L. Ramírez-Jiménez ◽  
Jeannette Barba León
Keyword(s):  
Drug Resistance ◽  
Foodborne Pathogens ◽  
Food Production ◽  
Pathogenic Bacteria ◽  
Multidrug Resistant ◽  
World Health ◽  
Economic Losses ◽  
Bacterial Drug Resistance ◽  
Health Organization ◽  
Therapeutic Doses

The drug abuse known to occur during growth of animals intended for food production, because of their use as either a prophylactic or therapeutic treatment, promotes the emergence of bacterial drug resistance. It has been reported that at least 25% of the foodborne isolates show drug resistance to one or more classes of antimicrobials (FAO 2018). There are diverse mechanisms that promote drug resistance. It is known that the use of sub-therapeutic doses of antibiotics in animals intended for food production promotes mutations of some chromosomal genes such as gyrA-parC and mphA, which are responsible for quinolone and azithromycin resistance, respectively. Also, the horizontal transfer of resistance genes as groups (“cassettes”) or plasmids makes the spread of resistance to different bacterial genera possible, among which there could be pathogens. The World Health Organization considers the emergence of multidrug-resistant pathogenic bacteria as a health problem, since the illnesses caused by them complicate the treatment and increase the morbidity and mortality rates. The complication in the illness treatment caused by a multidrug-resistant pathogen causes economic losses to patients for the payment of long stays in hospitals and also causes economic losses to companies due to the absenteeism of their workers.

scholarly journals Potential of Sambiloto (Andrographis paniculata Nees) Extract against Salmonella Pullorum

2022 ◽  
Author(s):  
Sri Hidanah ◽  
Emy Koestanti Sabdoningrum ◽  
Soeharsono . ◽  
Ayu Andira ◽  
Noor Amina Varhana
Keyword(s):  
Pathogenic Bacteria ◽  
Bacterial Resistance ◽  
Chemical Constituents ◽  
Disk Diffusion ◽  
Diffusion Method ◽  
Economic Losses ◽  
Biochemical Tests ◽  
Disk Diffusion Method ◽  
Salmonella Pullorum ◽  
Major Chemical

Background: Salmonella Pullorum are pathogenic bacteria that causes salmonellosis and causes heavy economic losses in the poultry industry and are zoonotic. Treatment of diseases caused by bacteria generally use antibiotics, but excessive administration of antibiotics causes bacterial resistance and residues in livestock. Major chemical constituents of Sambiloto are andrographolide and flavonoids. Andrographolide has antibacterial effect in addition to being antitoxic, anticancer, anti-inflammatory and antiallergic. Methods: The research was conducted by isolating and identifying Salmonella Pullorum on SSA media and a series of biochemical tests (TSIA, SIM, SCA, urea media and sugar test), manufacturing sambiloto extract, testing the sensitivity of several antibiotics using the disk diffusion method and testing the activation of sambiloto extract against Salmonella Pullorum using the disk diffusion and dilution methods. Result: The result show that sambiloto had antibacterial activity because it contained andrographolide, flavonoids, saponins, alkaloids and tannins and the lowest extract dose that effectively killed Salmonella Pullorum is concentrations of 20%.

Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections

2020 ◽  
Vol 20 (14) ◽  
pp. 1238-1263 ◽  
Author(s):  
Jiarui Li ◽  
Pablo Fernández-Millán ◽  
Ester Boix
Keyword(s):  
Bacterial Infections ◽  
Bacterial Resistance ◽  
Antimicrobial Agents ◽  
Resistance Mechanisms ◽  
Adjuvant Activity ◽  
Biofilm Growth ◽  
Intracellular Target ◽  
Conventional Antibiotics ◽  
Available Information ◽  
Toxic Concentrations

Background: Antimicrobial resistance (AMR) to conventional antibiotics is becoming one of the main global health threats and novel alternative strategies are urging. Antimicrobial peptides (AMPs), once forgotten, are coming back into the scene as promising tools to overcome bacterial resistance. Recent findings have attracted attention to the potentiality of AMPs to work as antibiotic adjuvants. Methods: In this review, we have tried to collect the currently available information on the mechanism of action of AMPs in synergy with other antimicrobial agents. In particular, we have focused on the mechanisms of action that mediate the inhibition of the emergence of bacterial resistance by AMPs. Results and Conclusion: We find in the literature many examples where AMPs can significantly reduce the antibiotic effective concentration. Mainly, the peptides work at the bacterial cell wall and thereby facilitate the drug access to its intracellular target. Complementarily, AMPs can also contribute to permeate the exopolysaccharide layer of biofilm communities, or even prevent bacterial adhesion and biofilm growth. Secondly, we find other peptides that can directly block the emergence of bacterial resistance mechanisms or interfere with the community quorum-sensing systems. Interestingly, the effective peptide concentrations for adjuvant activity and inhibition of bacterial resistance are much lower than the required for direct antimicrobial action. Finally, many AMPs expressed by innate immune cells are endowed with immunomodulatory properties and can participate in the host response against infection. Recent studies in animal models confirm that AMPs work as adjuvants at non-toxic concentrations and can be safely administrated for novel combined chemotherapies.

scholarly journals PROPAGATION OF ANTIMICROBIAL RESISTANT Salmonella spp. IN BIVALVE MOLLUSKS FROM ESTUARY AREAS OF BAHIA, BRAZIL

2016 ◽  
Vol 29 (2) ◽  
pp. 450-457 ◽  
Author(s):  
CARLA SILVA DA SILVEIRA ◽  
OSCARINA VIANA DE SOUSA ◽  
NORMA SUELY EVANGELISTA-BARRETO
Keyword(s):  
Nalidixic Acid ◽  
Bacterial Infections ◽  
Bacterial Resistance ◽  
Antimicrobial Agents ◽  
Resistance Index ◽  
Multidrug Resistant ◽  
Resistance Mechanisms ◽  
Bivalve Mollusks ◽  
Salmonella Spp ◽  
Development Of Resistance

ABSTRACT: In recent years, the emergence of resistant pathogens has complicated the treatment of bacterial infections in livestock production as well as in the medical field, due to the development of resistance mechanisms by microorganisms. The objective of this study was to delineate the antimicrobial resistance profile of Salmonella spp. strains isolated from bivalve mollusks (oysters and mussels) and from estuarine environment water of two regions of Bahia, Brazil. Twenty-seven strains, 12 isolated from bivalve mollusks and 15 from estuarine water, were tested. Eight antimicrobial agents (phenicol, beta-lactams, tetracyclines, quinolones and fluoroquinolones classes) were used for a susceptibility test, Minimum Inhibitory Concentration (MIC) and extended-spectrum beta-lactamases (ESBLs) production. Isolates showed high susceptibility to the classes of antimicrobial agents tested, with resistance only to nalidixic acid (27%), ampicillin (25%) and tetracycline (25%). Bacterial resistance was of chromosomal origin and the multidrug resistance index (MAR) among isolates of shellfish (mussels in natura) was 0.25. The MIC was found to be 100 µg/mL, 500 µg/mL and 350 µg/mL to nalidixic acid, ampicillin and tetracycline, respectively. None of the isolates presented ESBLs production. The presence of multidrug-resistant and high MIC Salmonella spp. is being conveyed in extraction areas of bivalve mollusks in the State of Bahia, Brazil.

scholarly journals Valorization of Winemaking By-Products as a Novel Source of Antibacterial Properties: New Strategies to Fight Antibiotic Resistance

Molecules ◽  
2021 ◽  
Vol 26 (8) ◽  
pp. 2331
Author(s):  
Adriana Silva ◽  
Vanessa Silva ◽  
Gilberto Igrejas ◽  
Isabel Gaivão ◽  
Alfredo Aires ◽  
...  
Keyword(s):  
Antibiotic Resistance ◽  
Bacterial Infections ◽  
Pathogenic Bacteria ◽  
Bacterial Resistance ◽  
Combined Therapy ◽  
Antibacterial Properties ◽  
Global Scale ◽  
Wine Industry ◽  
Alternative Solutions ◽  
By Products

The emergence of antibiotic-resistance in bacteria has limited the ability to treat bacterial infections, besides increasing their morbidity and mortality at the global scale. The need for alternative solutions to deal with this problem is urgent and has brought about a renewed interest in natural products as sources of potential antimicrobials. The wine industry is responsible for the production of vast amounts of waste and by-products, with associated environmental problems. These residues are rich in bioactive secondary metabolites, especially phenolic compounds. Some phenolics are bacteriostatic/bactericidal against several pathogenic bacteria and may have a synergistic action towards antibiotics, mitigating or reverting bacterial resistance to these drugs. Complex phenolic mixtures, such as those present in winemaking residues (pomace, skins, stalks, leaves, and especially seeds), are even more effective as antimicrobials and could be used in combined therapy, thereby contributing to management of the antibiotic resistance crisis. This review focuses on the potentialities of winemaking by-products, their extracts, and constituents as chemotherapeutic antibacterial agents.

Sign in / Sign up

Export Citation Format

Share Document